Pirandai (Cissus quadrangularis)

Cissus quadrangularis contains bioactive compounds including ketosteroids and triterpenes that stimulate osteoblast activity and collagen synthesis. This herb demonstrates evidence for accelerating bone healing and reducing joint inflammation through enhanced bone formation protein production.

Origin & History

Pirandai (Cissus quadrangularis) is a perennial succulent vine from the Vitaceae family, native to India, Africa, and Sri Lanka. It is sourced from the stems, leaves, and roots of the plant, with extracts commonly prepared using methanol, ethyl acetate, ethanol, or water extraction methods. The plant thrives in a wide range of soils and temperatures and belongs to a class rich in flavonoids, phytosterols, and triterpenoids.

Historical & Cultural Context

In Ayurvedic and African traditional medicine, Pirandai has been used for thousands of years to treat bone fractures, tissue repair, osteoporosis, digestive disorders, and wounds. Known as 'hadjod' in India specifically for bone healing properties, traditional preparations include stem paste for asthma, juice for scurvy and menstrual issues, and powder for hemorrhoids.

Health Benefits

• Accelerates bone fracture healing - small trial of 60 people showed 1,200 mg daily for 3 months promoted healing and raised bone formation proteins (limited evidence) • Reduces joint pain - 8-week study in 29 men found 3,200 mg daily significantly reduced exercise-induced joint pain (small sample size) • Speeds jaw fracture recovery - study in 9 people taking 500 mg 3x daily for 6 weeks showed faster healing with reduced pain and swelling (very limited evidence) • Potential anti-inflammatory effects - preclinical studies show reduction in TNF-α and oxidative stress markers (animal studies only) • Traditional use for digestive disorders - no clinical evidence provided, only traditional reports

How It Works

Cissus quadrangularis contains ketosteroids, triterpenes, and flavonoids that stimulate osteoblast proliferation and enhance collagen synthesis. The active compounds increase bone morphogenetic proteins (BMPs) and alkaline phosphatase activity, promoting bone matrix formation. These compounds also inhibit inflammatory cytokines like TNF-alpha and IL-6, reducing joint inflammation and pain.

Scientific Research

Human clinical trials on Cissus quadrangularis are limited to small studies with no large-scale RCTs or meta-analyses identified. The largest trial involved 570 people testing hemorrhoid symptoms but found no benefit over placebo. No PubMed PMIDs are provided in the available research, with most evidence being preclinical or anecdotal.

Clinical Summary

A randomized trial of 60 participants showed 1,200 mg daily for 3 months accelerated fracture healing and increased bone formation markers, though the sample size was limited. An 8-week study in 29 men found 3,200 mg daily significantly reduced exercise-induced joint pain compared to placebo. Additional small studies suggest benefits for osteoarthritis symptoms, but larger, longer-term trials are needed. Current evidence is promising but limited by small sample sizes and short durations.

Nutritional Profile

{"macronutrients": {"protein": "Approximately 5-7% of dry weight", "fiber": "Approximately 10-12% of dry weight"}, "micronutrients": {"vitamin_c": "Approximately 50-100 mg per 100g", "calcium": "Approximately 200-250 mg per 100g", "phosphorus": "Approximately 100-150 mg per 100g"}, "bioactive_compounds": {"ketosteroids": "Present, specific concentration not well-established", "flavonoids": "Present, specific concentration not well-established", "triterpenoids": "Present, specific concentration not well-established"}, "bioavailability_notes": "Nutrient absorption may vary based on preparation method; cooking or processing can enhance bioavailability of certain compounds."}

Preparation & Dosage

Clinically studied dosages include 500 mg three times daily (1,500 mg total) for fracture healing over 6 weeks, 1,200 mg daily for 3 months for bone health, and 3,200 mg daily for 8 weeks for joint pain. Studies used non-standardized extracts in powder, capsule, or syrup forms. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Calcium, Vitamin D3, Glucosamine, Boswellia, Turmeric

Safety & Interactions

Cissus quadrangularis is generally well-tolerated with mild gastrointestinal upset reported in some users. No significant drug interactions have been documented, though it may theoretically enhance effects of bone-building medications. Safety during pregnancy and breastfeeding has not been established, so use should be avoided. Individuals with hormone-sensitive conditions should consult healthcare providers due to potential estrogenic activity of some compounds.